Page last updated: 2024-12-10

echinenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

echinenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

echinenone : A carotenone that is beta-carotene in which the 4 position has undergone formal oxidation to afford the corresponding ketone. Isolated as orange-red crystals, it is widely distributed in marine invertebrates. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281236
CHEBI ID4746
SCHEMBL ID114770
MeSH IDM0275239

Synonyms (34)

Synonym
echinenone/ (myxoxanthin)
LMPR01070060
beta,beta-caroten-4-one
echinenone
432-68-8
C08592
aphanin
4-oxo-beta-carotene
4-keto-beta-carotene
CHEBI:4746
myoxanthin
2,4,4-trimethyl-3-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-2-en-1-one
2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-2-en-1-one
unii-lj5io02mnq
lj5io02mnq ,
einecs 207-083-4
4-oxo-.beta.-carotene
.beta.-echinenone
.beta.,.beta.-caroten-4-one
4-keto-.beta.-carotene
echinenone [mi]
echinenone (constituent of spirulina) [dsc]
all-trans-echinenone
SCHEMBL114770
echinenone, all-trans-
myxoxanthine
echinenon
.beta.-caroten-4-one, all-trans-
2-cyclohexen-1-one, 2,4,4-trimethyl-3-[3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3,5,7,9,11,13,15,17-octadecanonaenyl]-, (all-e)-
echinenone, >=95.0% (hplc)
Q1280339
DTXSID101026555
AKOS040734904
compound tnp-004859

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" This indicated that calves well absorbed fewer polar xanthophylls, echinenone and (3R)-3-hydroxyechinenone compared to the polar xanthophyll, astaxanthin."( Accumulation of xanthophylls from the phaffia yeast (Xanthophyllomyces dendrorhrous) in calves.
Katamoto, H; Kitahara, G; Maoka, T; Moritomo, Y; Okada, T; Tani, C; Tani, M, 2014
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
cofactorAn organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carotenone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
astaxanthin biosynthesis (bacteria, fungi, algae)413
echinenone and zeaxanthin biosynthesis (Synechocystis)112
astaxanthin biosynthesis (bacteria, fungi, algae)513

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (11.11)18.7374
1990's1 (2.78)18.2507
2000's14 (38.89)29.6817
2010's14 (38.89)24.3611
2020's3 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.44 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.70 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]